Diabetes Mellitus, Type 2 Clinical Trial
— ADAPTOfficial title:
Behavioral Family Systems Therapy for Teens With Type 2 Diabetes: A Pilot
Verified date | May 2017 |
Source | Nemours Children's Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a randomized, controlled pilot trial of Behavioral Family Systems Therapy for Teens with Type 2 Diabetes (BFST-DM2), an individual psychological intervention tailored to meet the needs of teens with type 2 diabetes. It is hypothesized that this behavioral family intervention will be feasible to implement with teens with type 2 diabetes and will have positive effects on treatment adherence, health outcomes like weight status and metabolic control, and psychological outcomes.
Status | Completed |
Enrollment | 24 |
Est. completion date | July 2016 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 11 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Diagnosed with type 2 diabetes mellitus for 6 months or more - Age-adjusted Body Mass Index at or above the 85th percentile (considered overweight) - Established diabetes care in Nemours Children's Clinic system or diabetes care meets minimum criteria for current American Diabetes Association Standards. - Adolescent lives at home in the study geographical area (Jacksonville, FL)over the course of the study duration (one year). - One caregiver in the home is willing to participate in the family intervention. Exclusion Criteria: - Adolescent has another systemic chronic disease other than well-controlled asthma. - Genetic syndrome or disorder (other than diabetes) known to affect glucose tolerance. - Daily use of glucocorticoids or other medications known to affect glucose tolerance. - Teen is enrolled in special education for students who have autism or are mentally handicapped. - Adolescent is pregnant or planning to be pregnant within 1 year. - Teen resides in temporary foster care, group home, or juvenile detention center. - The family has an open case with an agency investigating child abuse or neglect. - Adolescent has been in an inpatient psychiatric facility or substance abuse treatment in the past 6 months. |
Country | Name | City | State |
---|---|---|---|
United States | Nemours Children's Specialty Care | Jacksonville | Florida |
Lead Sponsor | Collaborator |
---|---|
Nemours Children's Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Body Mass Index (weight status) at 6 months and at 12 months | Body Mass Index (adjusted for height, gender, and age) - height and weight in kg and meters (kg/m^2) - change in BMI across time points is being studied - change in weight from baseline to 6 months and change in weight from baseline to 12 months | baseline, 6 months after baseline, 12 months after baseline | |
Secondary | metabolic control (HbA1c) | Metabolic control is measured using HbA1c values | baseline, 6 months after baseline, 12 months after baseline | |
Secondary | Treatment Adherence | Treatment Adherence is measured using the Diabetes Self Management Survey for Teens with Type 2 Diabetes. | baseline, 6 months after baseline, 12 months after baseline | |
Secondary | Family Problem-solving | Family problem-solving is measured using the Revised Diabetes Family Conflict Scale | baseline, 6 month after baseline | |
Secondary | Physical activity | Physical activity is measured by an accelerometer | baseline, 6 months after baseline | |
Secondary | Body Fat (weight status) | Body fat percent change - measured by a hand-held body fat impedance device | baseline, 6 months after baseline, 12 months after baseline | |
Secondary | Waist Circumference (weight status) | Waist circumference in cm | baseline, 6 months after baseline, 12 months after baseline | |
Secondary | Food intake | Nutrition/food intake as measured by the Nutrition Data Systems for Research interview | baseline, 6 months after baseline | |
Secondary | Family communication skills | Family communication skills are measured by the Family Communication (Interaction Behavior Code) | baseline, 6 months after baseline | |
Secondary | Teen Self-esteem | Teen Self-Perception/Self-esteem is measured by the Harter Self-Perception Profile | baseline, 6 months after baseline | |
Secondary | Teen Quality of Life | Teen Quality of Life is measured by The Pediatric Quality of Life Inventory (PedsQL) | baseline, 6 months after baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |